accountBritain is one of the worst countries in Europe for people with Multiple Sclerosis, according to the MS Society.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
MULTIPLE SCLEROSIS
Multiple sclerosis (MS) is an autoimmune condition that attacks the central nervous system. This topic tracks information on multiple sclerosis treatments and the financial impact on companies researching and developing new drugs to fight this terrible disease.
Multiple Sclerosis is part of Business Exchange, suggested by
Steve McCarthy.
This topic contains
967 news
and
242 blog
items.
Read updated news, blogs, and resources about Multiple Sclerosis. Find user-submitted articles and reactions on Multiple Sclerosis from
like-minded professionals.
News
Please add new articles to this topic
Narayan greeting Head of Physiology at JIPMER Madan Mohan Trakroo, during the inauguration of the Puducherry chapter of...
European Union regulators for a drug it makes with Biogen Idec Inc. (BIIB US) to improve walking in multiple sclerosis...
the backing of European Union regulators for a drug it makes with Biogen Idec to improve walking in multiple sclerosis...
A daily hop-on, hop-off ticket costs ?5 and a family ticket ?12. See dublinmountains.ie. Walk and barbecue Multiple...
the backing of European Union regulators for a drug it makes with Biogen Idec to improve walking in multiple sclerosis...
melanoma drug from Bristol-Myers Squibb(BMY). Fampyra, a drug used to improve the walking ability of patients with...
authorization of FAMPYRA ��� (prolonged-release fampridine 10 mg tablets) for the improvement of walking in adult...
Inc.| BIIB ?We are very pleased by the CHMP decision. Walking disability is a common symptom in multiple sclerosis...
Viagra drastically reduces multiple sclerosis symptoms in animal models with the disease, according to Universitat...
to keep the product on the market. Fampyra is used to help improve walking ability in patients with multiple sclerosis.
European Union regulators for a drug it makes with Biogen Idec Inc. (BIIB US) to improve walking in multiple sclerosis...
The European Medicines Agency's Committee for Medicinal Products for Human Use will grant Acorda Therapeutics' (Nasdaq:...
to keep the product on the market. Fampyra is used to help improve walking ability in patients with multiple sclerosis.
patients given that the drug is well tolerated and has been used to treat sexual dysfunction in some multiple sclerosis...
Insight on the approval of Acorda Therapeutics' multiple sclerosis drug, with Ron Cohen, Acorda Therapeutics...
If you're a fan of large-cap biotech stocks, we can talk about how the emergence of oral multiple sclerosis drugs is...
date as of the close of trading on Thursday. Acorda Therapeutics, Inc., a biotechnology company, develops therapies for...
trend. Caffeine has been credited with effects on many conditions and diseases, such as asthma, Alzheimer's and...
websites that empowers users with dexterity limitations that arise from a variety of conditions including stroke,...
in humans and in animal models in numerous acute and chronic diseases, ranging from orphan diseases such as multiple...
A chronic autoimmune disease, multiple sclerosis (MS) is estimated to impact 2.5 million people worldwide, with 1...
treat or ameliorate neural diseases or conditions associated with neuron or oligodendrocytes loss or dysfunction, such...
tale of a woman who suffers from CCSVI, or chronic cerebro-spinal venous insufficiency, which often affects people with...
(MARKETWIRE via COMTEX) -- The Multiple Sclerosis Society of Canada is pleased to announce that $6.6 million has been...
Top Sources: Multiple Sclerosis
- St. Petersburg Times
- Reuters
- Chicago Tribune
- MarketWatch
- Mail Online UK
- BBC
- Boston Globe
- Philadelphia Inquirer
- BusinessWeek
- Wall Street Journal Online
Post a Job
Jobs in this Topic
RN/Registered Nurse Clinical Coordinator - Ambulatory Mulitple Sclerosis Center
Rush University Medical Center
|
Chicago, IL
Posted: May 14